Back
Protagonist Therapeutics Vs. Lam Research Industry Stock Comparison
Buy
56
PTGX
Protagonist Therapeutics
Last Price:
46.94
Seasonality Move:
13.55%
Sell
42
LRCX
Lam Research
Last Price:
74.15
Seasonality Move:
17.09%
Buy
56
Protagonist Therapeutics (PTGX)
is a Buy
Is Protagonist Therapeutics a Buy, Sell or Hold?
- The current Protagonist Therapeutics [PTGX] share price is $47.64. The Score for PTGX is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- PTGX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
42
Lam Research (LRCX)
is a Sell
Is Lam Research a Buy, Sell or Hold?
- The current Lam Research [LRCX] share price is $76.40. The Score for LRCX is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- LRCX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PTGX Stock Price Chart
What is Protagonist Therapeutics's stock price today?
-
The Protagonist Therapeutics share price today is $47.64
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTGX is experiencing slight buying pressure.
LRCX Stock Price Chart
What is Lam Research's stock price today?
-
The Lam Research share price today is $76.40
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LRCX is experiencing selling pressure, which indicates risk of future bearish movement.
PTGX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.62 | Buy |
Relative Strength Index (14 RSI): | 65.65 | Buy |
Chaikin Money Flow: | 126936 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (44.19 - 46.41) | Buy |
Bollinger Bands (100): | (33.39 - 44.11) | Buy |
LRCX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.33 | Buy |
Relative Strength Index (14 RSI): | 41.76 | Sell |
Chaikin Money Flow: | -19870828 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (76.88 - 82.72) | Sell |
Bollinger Bands (100): | (78.24 - 101.22) | Sell |
PTGX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 44.87 | Buy |
20-day SMA: | 45.2 | Buy |
50-day SMA: | 43.19 | Buy |
200-day SMA: | 33.03 | Buy |
8-day EMA: | 45.46 | Buy |
20-day EMA: | 44.91 | Buy |
50-day EMA: | 42.95 | Buy |
200-day EMA: | 34.35 | Buy |
LRCX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 81.64 | Sell |
20-day SMA: | 80.71 | Sell |
50-day SMA: | 80.37 | Sell |
200-day SMA: | 89.73 | Sell |
8-day EMA: | 81.28 | Sell |
20-day EMA: | 80.83 | Sell |
50-day EMA: | 82.43 | Sell |
200-day EMA: | 84.85 | Sell |
Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.50 per share, and a decrease next year of $2.97 per share.
Lam Research Earnings Growth & LRCX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $26.45 per share, and a decrease next year of $26.17 per share.
Protagonist Therapeutics Technical Analysis
Oct 2 | Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
02 | 03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Lam Research Technical Analysis
Oct 2 | Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
02 | 03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |